Location History:
- Griesheim, DE (1994)
- Hofheim am Taunus, DE (1994)
Company Filing History:
Years Active: 1994
Title: **Innovative Contributions of Norbert Klesel in Pharmaceutical Sciences**
Introduction
Norbert Klesel, an accomplished inventor based in Griesheim, Germany, has made significant strides in the field of pharmaceutical inventions. With a total of two patents to his name, he has contributed to developing treatments that target serious bacterial infections and septic shock.
Latest Patents
Klesel's latest patents focus on pharmaceutical combination preparations that include cephalosporin and cefotaxime along with at least one xanthine derivative. These formulations are designed to effectively treat bacterial infectious diseases and provide therapeutic benefits in cases of septic shock. His innovations also encompass cephalosporin derivatives that are outlined in a general formula, which includes pharmaceutical preparations effective against bacterial infections, methods for producing these cephem derivatives, and their use in combating such infections.
Career Highlights
Norbert Klesel is currently associated with Hoechst Aktiengesellschaft, a prominent pharmaceutical company known for its innovations in medicine. His tenure at the company has allowed him to refine his expertise in developing effective therapeutic solutions that address critical health challenges.
Collaborations
Throughout his career, Klesel has collaborated with esteemed colleagues including Michael Limbert and Elmar Schrinner. These partnerships have fostered a creative environment that encourages the sharing of knowledge and ideas, leading to the successful development of innovative pharmaceutical products.
Conclusion
Norbert Klesel stands out as a significant figure in pharmaceutical innovation. His dedication to research and development has led to valuable patents that contribute to the medical field and improve patient outcomes. As he continues his work, the impact of his inventions is likely to be felt in the treatment of bacterial infections and related health complications in the years to come.